Marco Platania - Concepedia

Author

Marco Platania

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

Chiara Pellegrini, M Platania, M. Platania, Marco Platania

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Mario Negri Institute for Pharmacological Research Institut Català d'Oncologia Istituti di Ricovero e Cura a Carattere Scientifico

About

Marco Platania is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	493
2	Health Sciences	3	3	58
3	Public Health	1	1	29
4	Endocrinology	1	1	13
5	Gastroenterology	1	1	18

Marco Platania

Publications

Citations

H-Index

Page 1

	Year	Citations
Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours? Emilio Bajetta, Laura Catena, Giuseppe Procopio, Cancer Chemotherapy and Pharmacology OncologyMedicineAre CapecitabineSuitable TreatmentsRadiopharmaceutical Therapy	2006	241
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial Martin Schüler, James Chih‐Hsin Yang, K. Park, Annals of Oncology	2015	131
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Chemotherapy in Patients with Neuroendocrine Tumors Barbro Eriksson, Bruno Annibale, Emilio Bajetta, Neuroendocrinology	2009	94
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study Roberto Buzzoni, Sara Pusceddu, Emilio Bajetta, Annals of Oncology MedicineCancer ManagementBiliary CancerPathologyCancer Treatment	2014	68
Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer M. Pérol, Nick Pavlakis, E. Levchenko, Lung Cancer Patient-reported OutcomesMedicineCancer ManagementPathologyAlectinib Versus Crizotinib	2019	55
Single-Institution Series of Early-Stage Merkel Cell Carcinoma: Long-Term Outcomes in 95 Patients Managed with Surgery Alone Emilio Bajetta, Luigi Celio, Marco Platania, Annals of Surgical Oncology Surgical OncologyMedicineCancer ManagementPathologySurgery	2009	53
Neuroendocrine tumors of unknown primary site: Gold dust or misdiagnosed neoplasms? Laura Catena, E. Bichisao, Massimo Milione, Tumori Journal	2011	36
Cancer-related fatigue and depression: a monocentric, prospective, cross-sectional study in advanced solid tumors Riccardo Lobefaro, Simone Rota, Luca Porcu, ESMO Open	2022	34
Safety and Activity of Sorafenib in Different Histotypes of Advanced Renal Cell Carcinoma Giuseppe Procopio, Elena Verzoni, Arpine Gevorgyan, Oncology	2007	31
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study Giovanni Fucà, Luigi Mariani, Salvatore Lo Vullo, Scientific Reports	2019	31

Page 1